Literature DB >> 1090522

Inhibition of Escherichia coli by bovine colostrum and post-colostral milk. II. The bacteriostatic effect of lactoferrin on a serum susceptible and serum resistant strain of E. coli.

B Reiter, J H Brock, E D Steel.   

Abstract

Two strains of Escherichia coli were inhibited by complement-inactivated cow serum and to a lesser extent by precolostral calf serum devoid of specific antibodies. They were not inhibited by undiluted colostral whey or milk but colostral whey became bacteriostatic after dialysis or dilution in Kolmer saline and addition of precolostral calf serum or lactoferrin. The inhibition in all these fluids was due to iron-binding proteins (transferrin or lactoferrin). Undiluted dialysed milk was not inhibitory because of its low content of lactoferrin but became inhibitory after addition of 1 mg/ml of lactoferrin. The lack of inhibition in undiluted whey is due to the high concentration of citrate in colostral whey (and milk) and it is suggested that citrate competes with the iron-binding proteins for iron and makes it availabe to the bacteria. Addition of bicarbonate, which is required for the binding of iron by transferrin and lactoferrin, can overcome the effect of citrate; hence, the bacteriostatic effect of cow serum and precolostral calf serum is due to the presence of both transferrin and bicarbonate as well as the low lefel of citrate.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1090522      PMCID: PMC1445754     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  22 in total

1.  Studies on the immunity of the calf to colibacillosis. V. The experimental reproduction of enteric colibacillosis.

Authors:  E F Logan; W J Penhale
Journal:  Vet Rec       Date:  1972-10-28       Impact factor: 2.695

2.  Significance of milk pH in newborn babies.

Authors:  W A Cox; D B Gammack; L P Garrod
Journal:  Br Med J       Date:  1973-05-05

3.  A re-interpretation of bicarbonate-free ferric transferrin E.P.R. spectra.

Authors:  E M Price; J F Gibson
Journal:  Biochem Biophys Res Commun       Date:  1972-01-31       Impact factor: 3.575

4.  Mutations affecting iron transport in Escherichia coli.

Authors:  G B Cox; F Gibson; R K Luke; N A Newton; I G O'Brien; H Rosenberg
Journal:  J Bacteriol       Date:  1970-10       Impact factor: 3.490

5.  Inhibition of bacteria by lactoferrin and other iron-chelating agents.

Authors:  J D Oram; B Reiter
Journal:  Biochim Biophys Acta       Date:  1968-12-23

6.  Bacterial iron metabolism and immunity to Pasteurella septica and Escherichia coli.

Authors:  J J Bullen; H J Rogers
Journal:  Nature       Date:  1969-10-25       Impact factor: 49.962

Review 7.  Role of iron in host-parasite interactions.

Authors:  E D Weinberg
Journal:  J Infect Dis       Date:  1971-10       Impact factor: 5.226

8.  Iron transport in Escherichia coli: relationship between chromium sensitivity and high iron requirement in mutants of Escherichia coli.

Authors:  C C Wang; A Newton
Journal:  J Bacteriol       Date:  1969-06       Impact factor: 3.490

9.  Iron-binding proteins in milk and resistance to Escherichia coli infection in infants.

Authors:  J J Bullen; H J Rogers; L Leigh
Journal:  Br Med J       Date:  1972-01-08

10.  Significance of milk pH in newborn infants.

Authors:  V C Harrison; G Peat
Journal:  Br Med J       Date:  1972-12-02
View more
  31 in total

1.  Complete nucleotide sequence of human mammary gland lactoferrin.

Authors:  M W Rey; S L Woloshuk; H A deBoer; F R Pieper
Journal:  Nucleic Acids Res       Date:  1990-09-11       Impact factor: 16.971

2.  The protein structure of recombinant human lactoferrin produced in the milk of transgenic cows closely matches the structure of human milk-derived lactoferrin.

Authors:  Ellen A J Thomassen; Harrie A van Veen; Patrick H C van Berkel; Jan H Nuijens; Jan Pieter Abrahams
Journal:  Transgenic Res       Date:  2005-08       Impact factor: 2.788

3.  Nonspecific bactericidal activity of the lactoperoxidases-thiocyanate-hydrogen peroxide system of milk against Escherichia coli and some gram-negative pathogens.

Authors:  B Reiter; V M Marshall; C G Rosén
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

4.  Heterogeneity in utilization of N-glycosylation sites Asn624 and Asn138 in human lactoferrin: a study with glycosylation-site mutants.

Authors:  P H van Berkel; H A van Veen; M E Geerts; H A de Boer; J H Nuijens
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

5.  Damage of the outer membrane of enteric gram-negative bacteria by lactoferrin and transferrin.

Authors:  R T Ellison; T J Giehl; F M LaForce
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

6.  Bacteriostasis of Escherichia coli by milk. II. Effect of bicarbonate and transferrin on the activity of infant feeds.

Authors:  J M Dolby; S Stephens; P Honour
Journal:  J Hyg (Lond)       Date:  1977-04

7.  Ability of Neisseria gonorrhoeae, Neisseria meningitidis, and commensal Neisseria species to obtain iron from lactoferrin.

Authors:  P A Mickelsen; E Blackman; P F Sparling
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

8.  Colostrum hexasaccharide, a novel Staphylococcus aureus quorum-sensing inhibitor.

Authors:  A Srivastava; B N Singh; D Deepak; A K S Rawat; B R Singh
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

9.  In vitro growth inhibition of mastitis-causing coliform bacteria by bovine apo-lactoferrin and reversal of inhibition by citrate and high concentrations of apo-lactoferin.

Authors:  J G Bishop; F L Schanbacher; L C Ferguson; K L Smith
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

10.  Bacteriostatic and fungostatic action of catecholamide iron chelators.

Authors:  R J Bergeron; G T Elliott; S J Kline; R Ramphal; L St James
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.